Deutsch English Français

Contact

EP1311482

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1311482

EP1311482 - NON-IMIDAZOLE ARYLOXYPIPERIDINES AS H3 RECEPTOR LIGANDS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 28.12.2007 Database last updated on 07.10.2024
Most recent event Tooltip	10.07.2009	Lapse of the patent in a contracting state	published on 12.08.2009 [2009/33]
Applicant(s)	For all designated states Ortho-McNeil Pharmaceutical, Inc. 920 U.S. Route 202, P.O. Box 300 Raritan, NJ 08869-0602 / US
	[2007/08]
Former [2003/21]	For all designated states Ortho McNeil Pharmaceuticals, Inc. 920 U.S. Route 202, P.O. Box 300 Raritan, NJ 08869-0602 / US
Inventor(s)	01 / APODACA, Richard 8248 Station Village Lane 2216 San Diego, CA 92108 / US
	02 / CARRUTHERS, Nicholas, I. 14370 Silver Heights Road Poway, CA 92064 / US
	03 / DVORAK, Curt, A. 7657 Angeleno Road San Diego, CA 92126 / US
	04 / SHAH, Chandravadan, R. 14213 Dalhousie Road San Diego, CA 92129 / US
	05 / XIAO, Wei 4043 Carmel Springs Way San Diego, CA 92130 / US
	[2003/21]
Representative(s)	Mercer, Christopher Paul, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	[N/P]
Former [2003/21]	Mercer, Christopher Paul, et al Carpmaels & Ransford 43, Bloomsbury Square London WC1A 2RA / GB
Application number, filing date	01959582.6	06.08.2001
	[2003/21]
	WO2001US24660
Priority number, date	US20000223768P	08.08.2000 Original published format: US 223768 P
	US20010922619	06.08.2001 Original published format: US 922619
	[2003/21]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0212190
	Date:	14.02.2002
	Language:	EN
	[2002/07]
	Type:	A2 Application without search report
	No.:	EP1311482
	Date:	21.05.2003
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 14.02.2002 takes the place of the publication of the European patent application.
	[2003/21]
	Type:	B1 Patent specification
	No.:	EP1311482
	Date:	21.02.2007
	Language:	EN
	[2007/08]
Search report(s)	International search report - published on:	EP	01.08.2002
Classification	IPC:	C07D211/46, C07D211/44, C07D401/12, A61K31/4465, A61K31/496, A61K31/5355, A61K31/4402, A61P25/00, A61P9/00	[2003/21]
	CPC:	C07D207/325 (EP,US); C07D401/12 (EP,KR,US); A61K31/4402 (EP,US); A61K31/4465 (EP,US); A61K45/06 (EP,US); A61P11/06 (EP); (+) A61P25/00 (EP); A61P25/06 (EP); A61P25/08 (EP); A61P25/18 (EP); A61P25/24 (EP); A61P25/28 (EP); A61P27/16 (EP); A61P37/08 (EP); A61P43/00 (EP); A61P9/00 (EP); C07C217/22 (EP,US); C07C323/25 (EP,US); C07C335/32 (EP,US); C07D207/335 (EP,US); C07D211/22 (EP,US); C07D211/46 (EP,US); C07D211/58 (EP,US); C07D213/36 (EP,US); C07D213/74 (EP,US); C07D215/06 (EP,US); C07D231/12 (EP,US); C07D233/42 (EP,US); C07D233/54 (EP,US); C07D233/56 (EP,US); C07D233/84 (EP,US); C07D233/88 (EP,US); C07D235/06 (EP,US); C07D235/26 (EP,US); C07D239/34 (EP,US); C07D249/08 (EP,US); C07D257/04 (EP,US); C07D277/36 (EP,US); C07D295/088 (EP,US); C07D295/096 (EP,US); C07D295/112 (EP,US); C07D295/135 (EP,US); C07D295/205 (EP,US); C07D307/52 (EP,US); C07D317/28 (EP,US); C07D333/20 (EP,US); C07D401/14 (EP,US); C07D471/08 (EP,US) (-)
	C-Set:	A61K31/4402, A61K2300/00 (EP,US); A61K31/4465, A61K2300/00 (US,EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/21]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	NICHT-IMIDAZOL ARYLOXYPIPERIDINE ALS H3 REZEPTOR LIGANDEN	[2003/21]
	English:	NON-IMIDAZOLE ARYLOXYPIPERIDINES AS H3 RECEPTOR LIGANDS	[2003/21]
	French:	ARYLOXYPIPERIDINES NON-IMIDAZOLE	[2003/21]
Entry into regional phase	07.03.2003	National basic fee paid
	07.03.2003	Designation fee(s) paid
	07.03.2003	Examination fee paid
Examination procedure	12.02.2002	Request for preliminary examination filed International Preliminary Examining Authority: EP
	07.03.2003	Amendment by applicant (claims and/or description)
	07.03.2003	Examination requested [2003/21]
	08.03.2004	Despatch of a communication from the examining division (Time limit: M06)
	12.11.2004	Reply to a communication from the examining division
	17.03.2006	Communication of intention to grant the patent
	31.08.2006	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
	25.10.2006	Fee for grant paid
	25.10.2006	Fee for publishing/printing paid
Opposition(s)	22.11.2007	No opposition filed within time limit [2008/05]
Request for further processing for:	25.10.2006	Request for further processing filed
	25.10.2006	Full payment received (date of receipt of payment) Request granted
	16.11.2006	Decision despatched
	12.11.2004	Request for further processing filed
	12.11.2004	Full payment received (date of receipt of payment) Request granted
	29.11.2004	Decision despatched
Fees paid	Renewal fee
	07.03.2003	Renewal fee patent year 03
	12.08.2004	Renewal fee patent year 04
	12.08.2005	Renewal fee patent year 05
	14.08.2006	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	21.02.2007
	[2009/33]
Cited in	International search	[A]US5182291 (GUBIN JEAN [BE], et al) [A] 1-60 * the whole document *;
		[AD]US5352707 (POMPONI SHIRLEY A [US], et al) [AD] 1-60 * the whole document *;
		[AD]EP0978512 (BIOPROJET SOC CIV [FR]) [AD] 1-60 * the whole document *;
		[AD] - IAN D. LINNEY ET AL., "Design, synthesis, and Structure-Activity Relationships of novel Non-imidazole Histamine H3 receptor Antagonists", JOURNAL OF MEDICINAL CHEMISTRY., AMERICAN CHEMICAL SOCIETY., US, (20000520), vol. 43, no. 12, ISSN 0022-2623, pages 2362 - 2370, XP001019293 [AD] 1-60 * the whole document * DOI: http://dx.doi.org/10.1021/jm990952j
		[AD] - C. ROBIN GANELLIN ET AL., "Synthesis of Potent Non-imidazole Histamine H3-Receptor antagonists", ARCHIV DER PHARMAZIE., VCH VERLAGSGESELLSCHAFT MBH, WEINHEIM., DE, (1998), vol. 331, ISSN 0365-6233, pages 395 - 404, XP002123596 [AD] 1-60 * the whole document * DOI: http://dx.doi.org/10.1002/(SICI)1521-4184(199812)331:12<395::AID-ARDP395>3.0.CO;2-7
		[A] - H: STARK ET AL., "General Construction Pattern of Histamine H3-Receptor Antagonists: Change of a paradigm", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (1998), no. 8, ISSN 0960-894X, pages 2011 - 2016, XP004137177 [A] 1-60 * the whole document * DOI: http://dx.doi.org/10.1016/S0960-894X(98)00342-4

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p